Sonam Suman

Statistics

Publications

Citations

119

H-Index

Active since

2019

Affiliations

Homi Bhabha National Institute(Current)

Tata Memorial Hospital

Bhabha Atomic Research Centre

Sonam Suman is an author at Homi Bhabha National Institute specializing in metastatic castration-resistant prostate cancer, oncology, and prostate cancer radioligand therapy.

Publications per year

2019–2021

Publications

Therapeutic efficacy, prognostic variables and clinical outcome of 177Lu-PSMA-617 PRLT in progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-à-vis Gleason score in such cohort

Sonam Suman, Rahul V. Parghane, Amit Joshi et al. · British Journal of Radiology · 2019 · 62 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Examining Absorbed Doses of Indigenously Developed 177 Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy

Kamaldeep Kamaldeep, Gaurav Wanage, Sudeep Sahu et al. · Cancer Biotherapy and Radiopharmaceuticals · 2020 · 25 citations

Medicine, Nuclear Medicine, Oncology +17

Combined 177Lu‐PSMA‐617 PRLT and abiraterone acetate versus 177Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability

Sonam Suman, Rahul V. Parghane, Amit Joshi et al. · The Prostate · 2021 · 22 citations

Medicine, Oncology, Pharmacology +17

Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course?

Sandip Basu, Rahul V. Parghane, Sonam Suman et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 10 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

1–4 of 4